Wang L, Xu X, Shang B, Sun J, et al. High farnesoid X receptor expression predicts favorable clinical outcomes in PDL1(low/negative) nonsmall cell lung cancer patients receiving antiPD1based chemoimmunotherapy. Int J Oncol 2022;60.
PMID: 35211760